Cyto Research Institute is categorized under Commercial Medical Research in Las Vegas, NV and active since 2003.
Cyto Research Institute was established in 2003, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Randolph R Smith at the company’s single location by writing to 4535 West Sahara Avenue # 200, Las Vegas, Nevada NV 89102 or by phoning (702) 933-4034. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Cyto Research Institute |
| Contact Person: | Randolph R Smith |
| Address: | 4535 West Sahara Avenue # 200, Las Vegas, Nevada 89102 |
| Phone Number: | (702) 933-4034 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2003 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Cyto Research Institute was started in 2003 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Randolph R Smith for inquiries that concern Cyto Research Institute by calling the company number (702) 933-4034, as your correspondence is most welcome. Additionally, the physical location of the single location of Cyto Research Institute can be found at the coordinates as well as the street address 4535 West Sahara Avenue # 200 in Las Vegas, Nevada 89102.
For its online presence, you may visit Cyto Research Institute’s website at and engage with its social media outlets through on Twitter and on Facebook.